These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3937926)
21. Effects of monocrotaline treatment on norepinephrine removal by isolated, perfused rat lungs. Hilliker KS; Imlay M; Roth RA Biochem Pharmacol; 1984 Aug; 33(16):2690-2. PubMed ID: 6431990 [No Abstract] [Full Text] [Related]
22. Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension. Kato S; Sugimura H; Kishiro I; Machida M; Suzuki H; Kaneko N Exp Lung Res; 2002 Jun; 28(4):265-73. PubMed ID: 12042029 [TBL] [Abstract][Full Text] [Related]
23. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats. Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320 [TBL] [Abstract][Full Text] [Related]
24. [Experimental glomerulopathy induced by monocrotaline in rats]. Yoshida M; Kimura T; Fukutomi K; Maemura T; Nagasawa T Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):109-14. PubMed ID: 3090323 [No Abstract] [Full Text] [Related]
25. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats. Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725 [TBL] [Abstract][Full Text] [Related]
26. Monocrotaline-induced pulmonary vascular disease after contralateral lung transplantation in the rat. Kawaguchi AT; Kawashima Y; Ishibashi-Ueda H; Mizuta T; Kitoh Y; Kunieda T J Heart Lung Transplant; 1993; 12(2):325-8; discussion 328-9. PubMed ID: 8476905 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats. Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786 [TBL] [Abstract][Full Text] [Related]
28. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Sudoh K; Sasamata M; Miyata K Eur J Pharmacol; 2004 Aug; 496(1-3):129-39. PubMed ID: 15288584 [TBL] [Abstract][Full Text] [Related]
29. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation. Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386 [TBL] [Abstract][Full Text] [Related]
30. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]. Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852 [TBL] [Abstract][Full Text] [Related]
31. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering. Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214 [TBL] [Abstract][Full Text] [Related]
32. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats. Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069 [TBL] [Abstract][Full Text] [Related]